Skip to main content

Table 3 MOG-Ab titer and prognosis

From: Clinical characteristics and prognosis of pediatric myelin oligodendrocyte glycoprotein antibody-associated diseases in China

 

Number of cases(%)

Serum MOG-Ab titer (n = 30, range = 1:10‒1000)

 ≤ 1:32

13 (43.3)

 ≥ 1:100 to < 1:320

10 (33.3)

 ≥ 1:320

7 (23.3)

CSF MOG-Ab titer (n = 9, range = 1:1‒10)

 ≥ 1:1 to < 1:3.2

3 (37.5)

 ≥ 1:3.2 to < 1:10

2 (25.0)

 ≥ 1:10

3 (37.5)

Serum MOG-Ab titer prognosis

 Became negative

11 (36.7)

 Decreased

4 (13.3)

 Maintained

2 (6.7)

 Increased, then decreased

3 (10.0)

 Became negative, then relapsed

4 (13.3)

 Became negative, then relapsed, then became negative

1 (3.3)

 Became negative, then relapsed, then decreased

2 (6.7)

 Decreased, and then increased

2 (6.7)

 Decreased, then increased, then decreased

1 (3.3)

  1. MOG-Ab myelin oligodendrocyte glycoprotein antibody, CSF cerebrospinal fluid